Genetic and non-genetic theories on the etiology of polycystic ovary syndrome

References

• Stein I. F., Leventhal M. L. Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 1935; 29: 181–91
   Google Scholar
• Barnes R. B., Rosenfield R. L., Burstein S., Ehrmann D. A. Pituitary-ovarian responses to nafarelin in the polycystic ovary syndrome. N. Engl. J. Med. 1989; 320: 559–65
   PubMed Web of Science ®Google Scholar
• Barnes R. B., Ehrmann D. A., Brigell D. F., Rosenfield R. L. Ovarian steroidogenesis responses to gonadotropin releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocortico-tropin suggestive of 3bT-hydroxy-DL5-steroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 1993; 76: 450–5
   PubMedGoogle Scholar
• Compo S., Felli A., Lamanna M. A., Barini A., Garcea N. Endocrine changes and clinical outcome after laparoscopic ovarian resection in women with polycystic ovaries. Hum. Re-prod. 1993; 8: 359–63
   PubMedGoogle Scholar
• Stewart P. M., Shackleton C. H. L., Beastall G. H., Edwards C. R. W. 5X-Reduc-tase activity in polycystic ovary syndrome. Lancet 1990; 335: 431–3
   PubMed Web of Science ®Google Scholar
• Gelderen C. J. V., Comes dos Santos M. L. L. Polycystic ovary syndrome. Evidence foran autoimmune mechanism in some cases. J. Reprod. Med. 1993; 38: 381–6
   PubMedGoogle Scholar
• Carey A. H., Chan K. L., Short F., White D., Williamson R., Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf.) 1993; 38: 653–8
   PubMed Web of Science ®Google Scholar
• Dowse G. The thrifty genotype in non-insulin dependent diabetes. The hypothesis survives. Br. Med. J. 1993; 306: 532–5
   PubMed Web of Science ®Google Scholar
• Hague W. M., Millar D. R. Excessive testosterone secretion in pregnancy. Case report. Br. J. Obstet. Gynaecol. 1985; 92: 173–8
   PubMedGoogle Scholar
• Kadylak B., Janowiak Z. Degenaratio cystica ovarii neonatorum. Zentralbl. Gynakol. 1991; 113: 285–9
   PubMedGoogle Scholar
• Mulaikal R. M., Migeon C. J., Rock J. A. Fertility rates in female patients with congenita] adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 1987; 316: 178–82
   PubMed Web of Science ®Google Scholar
• Insler V., Lunenfeld B. Pathophysiology of polycystic ovarian disease: new insights. Hum. Reprod. 1991; 6: 1025–9
   PubMed Web of Science ®Google Scholar
• Phillips K., Barker D. J. P., Hales C. N., Fall C. H. D., Osmond C., Clark P. M. S. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36: 225–8
   PubMedGoogle Scholar
• Jahanfar S., Eden J. A., Warren P., Seppala M., Nguyent T. V. A twin study of polycystic ovary syndrome. Fertil. Steril. 1995; 63: 478–86
   PubMed Web of Science ®Google Scholar
• Kazer R. The aetiology of polycystic ovary syndrome (PCO). Med. Hypotheses 1989; 30: 151–5
   PubMedGoogle Scholar
• Mechanick J., Futterweit W. Hypothesis: aberrant puberty and the Stein-Levanthal syndrome. Int. J. Fertil. 1984; 29: 35–8
   PubMedGoogle Scholar
• Orenstein H., Raskind M. A. Polycystic ovary disease in two patients with Briquet's disorder. Am. J. Psychiatry 1983; 140: 1202–4
   PubMedGoogle Scholar
• McCluskey S., Evans C., Lacey J. H., Pearce J. M., Jacobs H. Polycystic ovary syndrome and bulimia. Fertil. Steril. 1992; 55: 287–91
   Google Scholar
• McCluskey S. E., Lacey J. H., Pearce J. M. Binge-eating and polycystic ovaries [letter]. Lancet 1992; 340: 723
   PubMed Web of Science ®Google Scholar
• Killen J. D., Hayward C., Litt I., Hammer L. D., Wilson D. M., Miner B., Taylor C. B., Varady A., Shisslak C. Is puberty a risk factor for eating disorders. Am. J. Dis. Child. 1992; 146: 323–5
   PubMedGoogle Scholar
• Yen S. S. C. The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 1980; 12: 177–208
   PubMed Web of Science ®Google Scholar
• Dewailly D., Coetet-Rudelli C. Insulin resistance and polycystic ovarian syndrome. Horm. Res. 1992; 38: 41–5
   PubMedGoogle Scholar
• Obhria M., Lynch S. S., Holder G., Jackson R., Tang L., Butt W. R. Hormonal studies on women with polycystic ovaries diagnosed by ultrasound. Clin. Endocrinol. (Oxf.) 1990; 32: 467–74
   PubMedGoogle Scholar
• Puzigaca Z., Prelevic G. M., Stretenoric Z., Balint-Peric L. Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol. Endocrinol. 1991; 5: 167–74
   PubMed Web of Science ®Google Scholar
• Rittmaster R. S., Thompson D. L. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J. Clin. Endocrinol. Metab. 1990; 70: 1096–102
   Google Scholar
• Ehrmann D. A., Rosenfield R. L., Barnes R. B., Brigell D. F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med. 1992; 327: 157–62
   PubMed Web of Science ®Google Scholar
• Cedars M. L., Steingold K. A., deZiegler D., Lapolt P. S., Chang R. J., Judd H. L. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. Fertil. Steril. 1992; 57: 495–500
   PubMed Web of Science ®Google Scholar
• Poison D. W., Adams J., Steen P. J., Franks S. Unilateral polycystic ovary. Case report. Br. J. Obstet. Gynaecol 1986; 93: 1110–3
   Google Scholar
• Hammond J. M., Baranao J. L. S., Skaleris D., Knight A. B., Romanus J. A., Matthew M. R. Production of insulin-like growth factors by ovarian granulosa cells. Endocrinology 1985; 117: 2553–5
   PubMed Web of Science ®Google Scholar
• Adashi E. Y., Resnick C. E., Brodie A. M. H., Svoboda M. E., Van Wyk J. Soma-tomedin-C mediated potentiation of follicle stimulating hormone induced aromatase activity of cultured rat granulosa cells. Endocrinology 1985; 117: 2313–20
   PubMed Web of Science ®Google Scholar
• Adashi E. Y., Resnick C. E., Hernandez E. R., May J. V., Knecht M., Svobodo M. E., Wyk J. J. V. Insulin-like growth factor-I as an amplifier of follicle-stimulating hormone action: studies on mechanism(s) and side(s) of action in cultured rat granulosa cells. Endocrinology 1988; 122: 1583–91
   PubMedGoogle Scholar
• Erickson G. F., Magoffin D. A., Cragun J. R., Chang R. J. The effects of insulin and insulin-like growth factor-I and II on estradiol production by granulosa cells of polycystic ovaries. J. Clin. Endocrinol. Metab. 1990; 70: 894–902
   PubMed Web of Science ®Google Scholar
• Hernandez E. R., Roberts C. T., Hurwitz A., LeRoith D., Adashi E. Y. Rat ovarian insulin-like growth factor II gene expression is theca-interstitial cell-exclusive: hormonal regulation and receptor distribution. Endocrinology 1990; 127: 3249–51
   PubMedGoogle Scholar
• Insler V., Shoham Z., Barash A., Koistinen R., Seppälä M., Hen M., Lunenfeld B., Zadik Z. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum. Reprod. 1993; 8: 379–83
   Google Scholar
• Mondschein J. S., Smith S. A., Hammond J. M. Production of insulin-like growth factor binding proteins (IGFBPs) by porcine granulosa cells: identification of IGFBP-2 and -3 and regulation by hormones and growth factors. Endocrinology 1990; 127: 2298–306
   PubMedGoogle Scholar
• Suikkari A. M., Ruutiainen K., Erkkola R., Seppaulau M. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum. Reprod. 1989; 4: 136–9
   PubMed Web of Science ®Google Scholar
• Conway G. S., Jacobs H. S., Holly J. M. P., Wass J. A. H. Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 1990; 33: 593–603
   PubMed Web of Science ®Google Scholar
• Pekonen F., Laatikainen T., Buyalos R., Rutanen E. M. Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease. Fertil. Steril. 1989; 51: 972–5
   PubMedGoogle Scholar
• Gataldo N. A., Giudice L. C. Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome.J. Clin. Endocrinol. Metab. 1992; 74: 695–7
   Google Scholar
• Gospodarwicz D., Bialecki H. Fibroblast and epidermal growth factors as mitogenic agents for cultured granulosa cells of rodent, porcine and human origin. Endocrinology 1979; 104: 757–64
   PubMedGoogle Scholar
• Mason H. D., Margara R., Winston R. M. L., Beard R. W., Reed M. J., Franks S. Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal polycystic ovaries. Clin. Endocrinol. (Oxf.) 1991; 33: 511–17
   Google Scholar
• Anaplitou L. G., Syrigos K., Panayiotakopoulos G., Kalos A., Batrinos M. L. Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovarian syndrome. Horm. Res. 1989; 31: 119–24
   PubMedGoogle Scholar
• Chang R. J., Nakaruma R. M., Judd H. L., Kaplan S. A. Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1983; 57: 356–9
   PubMed Web of Science ®Google Scholar
• Lanzone A., Fulghesu A. M., Pappalardo S., Proto C., LeDonne M., Andreani C. L. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Gynecol. Obstet. Invest. 1990; 29: 149–53
   PubMedGoogle Scholar
• Burghen G. A., Givens J. R., Kitabchi A. E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1980; 50: 113–16
   PubMed Web of Science ®Google Scholar
• Urdle W. Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstet. 1988; 243: 13–36
   PubMedGoogle Scholar
• Cooper H. E., Spellacy W. N., Prem K. A., Cohen W. D. Hereditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 1968; 100: 371–87
   PubMed Web of Science ®Google Scholar
• Givens J. R., Andersen R. N., Umstot E. S., Wiser W. L. Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels. Obstet. Gynecol. 1976; 47: 388–94
   PubMedGoogle Scholar
• Wilroy R. S., Givens J. R., Wiser W. L., Coleman S. A., Andersen R. N., Fish S. A. Hyperthecosis, an inheritance form of polycystic ovary. I. Clinical and histologic features. J. Clin. Endocrinol. (Oxf) 1962; 22: 326–8
   Google Scholar
• Givens J. R. Familial polycystic ovarian disease. Endocrinol. Metab. Clin. North Am. 1988; 17: 771–83
   PubMed Web of Science ®Google Scholar
• Ferriman D., Purdie A. W. The inheritance of PCO and possible relationship to premature balding. Clin. Endocrinol. (Oxf.) 1979; 11: 771–83
   Google Scholar
• Lunde O., Magnus P., Sandvik L., Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 1989; 28: 23–30
   PubMed Web of Science ®Google Scholar
• Hague W. M., Adams J., Reeders S. T., Peto T. E. A., Jacobs H. S. Familial polycystic ovaries: a genetic disease. Clin. Endocrinol. (Oxf.) 1988; 29: 593–605
   PubMed Web of Science ®Google Scholar
• Goldzieher J. W., Green J. A. The polycystic ovary. I. Clinical and histologic features. J. Clin. Endocrinol. (Oxf.) 1962; 22: 325–38
   PubMed Web of Science ®Google Scholar
• JefFcoate T. N. A. The androgenic ovary, with special reference to the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 1964; 88: 143–56
   PubMedGoogle Scholar
• McDonough P. G., Mahesh V. B., Ellegood J. O. Steroid, follicle-stimulating hormone, and luteinizing hormone profiles in identical twins with polycystic ovaries. Am. J. Obstet. Gynecol. 1972; 113: 1072–6
   PubMedGoogle Scholar
• Lee P. A., Migeon C. J., Bias W. B., Jones G. S. Familial hypersecretion of adrenal androgens transmitted as a dominant, non-HLA linked trait. Obstet. Gynecol. 1987; 69: 259–65
   PubMedGoogle Scholar
• Parker R., Ming P. L., Rajan R., Goodner D. M., Reme A. Clinical and cytologi-cal studies of patients with polycystic ovary disease. Am. J. Obstet. Gynecol. 1980; 137: 656–60
   PubMedGoogle Scholar
• Zarate A., Garcia-Reyes J. A., Castelazo-Ayala L., Estevez R., Silva J. Turner's pheno-type with menstruation, XO karyotype and germ cells in the ovary. Obstet. Gynecol. 1969; 33: 818–21
   PubMedGoogle Scholar
• Williams G. H., Rose L. I., Jagger P. I., Lauler D. P. A Turner's syndrome variant with polycystic ovaries and idiopathic myocardial hypertrophy. Ann. Intern. Med. 1969; 70: 571–6
   PubMedGoogle Scholar
• Netter A., Bloch-Michel H., Salomon Y., Ther-Vet F., de Grouchy J., Lamy M. Study of karyotypes in Stein-Leventhal syndrome. Ann. Endocrinol. (Paris) 1961; 22: 841–9
   PubMedGoogle Scholar
• Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf) 1989; 31: 87–120
   PubMed Web of Science ®Google Scholar
• Surrey E. S., de Ziegler D., Lu J. K. H., Chang R. J., Judd H. L. EfTects of gonadotropin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease. Fertil. Steril. 1989; 52: 547–52
   PubMedGoogle Scholar
• Williams I. A., Show R. W., Burford G. An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotropin hormone releasing hormone agonist - Nafarelin. Clin. Endocrinol. (Oxf) 1989; 31: 345–53
   PubMedGoogle Scholar
• Pang S., Softness B., Sweeney W. J., New M. I. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N. Engl. J. Med. 1987; 316: 1295–301
   PubMedGoogle Scholar
• Winchester B., Young E., Geddes S., Genet S., Hurst J., Middleton-Price H., Williams N., Webb M., Habel A., Malcolm S. Female twin with Hunter's disease due to nonran-dom inactivation of the X chromosome: a consequence of twinning. Am. J. Med. Genet. 1992; 44: 834–8
   PubMed Web of Science ®Google Scholar
• Richards C. S., Watkins S. C., Hoffman E. P., Schneider N. R., Milsark N. R., Katz K. S. Skewed X inactivation in a female MZ twin results in Duchenne muscular distrophy. Am. J. Hum. Genet. 1990; 46: 627–81
   Google Scholar